Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

News · September 19, 2023

ANA 2023: Lower Topiramate Doses May Be Sufficient in Patients With Epilepsy

Topiramate serum level >10 mg/L may increase risk for ataxia without additional benefit of seizure control

PracticeUpdate Editorial Team


Further Reading